Autism Rates And Thimerosal-Free Vaccines: A Study

Despite concerns that vaccines may cause autism, scientists and health experts have found no link between the two. Thimerosal, a mercury-based preservative previously found in many childhood vaccines, has been a particular point of concern. However, studies have shown that autism rates did not decline when thimerosal was removed from vaccines. For example, a 2004 report by the Institute of Medicine found no data to support thimerosal as a cause of autism, and a 2008 study in California showed that autism rates continued to rise even after thimerosal was removed from most vaccines in 2001. Similarly, studies in Denmark and Sweden found that autism rates continued to increase after thimerosal was removed from vaccines in 1992 and 1996, respectively. The scientific community attributes the rise in autism rates to improved diagnostic tools, better access to care, and greater societal acceptance of autism.

Explore related products

Thimerosal: Let the Science Speak: The Evidence Supporting the Immediate Removal of Mercury―a Known Neurotoxin―from Vaccines

$19.19 $14.95

Inoculated: How Science Lost its Soul in Autism

$16.99 $24.99

De La Cruz Merthiolate Tincture Antiseptic - First Aid for Minor Cuts, Scrapes and Burns - Mercury-Free Formula Safe for The Entire Family (3 Bottles)

$12.98 $15.98

Germa Mercuro-chrome Mercury Free First Aid Antiseptic Liquid 1 oz

$7.28

Germa Merthiolate Tincture Antiseptic 1 oz

$7.53 $7.99

Betadine Antiseptic First Aid Solution, Povidone-iodine 10%, Infection Protection, Kills Germs In Minor Cuts Scrapes And Burns, No Sting Promise, No Alcohol or Hydrogen Peroxide, 8 FL OZ

$13.29 $17.38

Thimerosal-containing vaccines and autism

Thimerosal is a preservative used in vaccines to prevent microbial growth and contamination. It has been used in vaccines since the 1930s and is composed of approximately 50% mercury by weight. Due to concerns about paediatric exposure to mercury through vaccine administration, thimerosal was removed from many vaccines in 1999.

Despite this removal, autism rates have continued to increase, which is contrary to what would be expected if thimerosal caused autism. Studies conducted in Denmark, Sweden, Quebec, and the United States have failed to find a link between thimerosal-containing vaccines and autism. In Denmark, researchers compared autism incidence in children who received varying amounts of thimerosal, finding no relationship between exposure and autism. Similarly, in Quebec, researchers grouped children by date of birth and estimated thimerosal exposure based on vaccine schedules, again finding no association between thimerosal exposure and autism diagnosis.

The Immunization Safety Review Committee of the Institute of Medicine also rejected the hypothesis of a causal relationship between thimerosal-containing vaccines and autism in 2004. A 2010 study by the Centers for Disease Control and Prevention (CDC) further supported this conclusion, finding no increased risk for autism spectrum disorder (ASD) associated with prenatal and infant exposure to thimerosal-containing vaccines.

Additionally, a report from California found that autism cases continued to increase even after the removal of thimerosal from most childhood vaccines. This suggests that exposure to thimerosal is not a primary cause of autism. While concerns about a potential link between thimerosal and autism persist, the weight of the evidence suggests that there is no causal relationship between thimerosal-containing vaccines and autism.

Explore related products

Thimerosal : Let the Science Speak: The Evidence Supporting the Immediate Removal of Mercury--A Known Neurotoxin--From Vaccines (Paperback - Revised Ed.)--by Robert F. Jr. Kennedy [2015 Edition]

$45.14

By Author Thimerosal: Let the Science Speak: The Evidence Supporting the Immediate Removal of Mercuryƒ??a Know

$69.68

Thimerosal and Vaccine Policy in the United States: CDC Policy, Scientific Controversies, and the Future of Public Health Immunization Standards

$6.99 $15.99

Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders

$35.99

Forbidden Facts: Government Deceit & Suppression About Brain Damage from Childhood Vaccines

$5 $32.99

Thimerosal and mercury poisoning

Thimerosal is a mercury-based preservative that has been used for decades in the United States in multi-dose vials of medicines and vaccines. It is an antibacterial compound that has been used effectively in multi-dose vaccine preparations for over 50 years. Thimerosal is approximately 50% mercury by weight and has been one of the most widely used preservatives in vaccines. It is added to prevent microbial growth and contamination that may occur due to the reuse of multi-dose vials.

Thimerosal was first introduced in the 1930s, and prior to its introduction, data from studies on animals and humans provided evidence for its safety and effectiveness as a preservative. Since then, Thimerosal has been studied extensively, and scientists have found no evidence that it causes harm other than minor local reactions at the site of injection. In fact, thimerosal has been found to be safe even for children, with no evidence of neurologic problems in those exposed to mercury-containing vaccines.

Despite the evidence supporting the safety of Thimerosal, concerns have been raised about its potential link to autism. Some people have attributed the increased prevalence of autism in recent years to higher exposure to Thimerosal from childhood vaccines. However, multiple studies from various countries, including Denmark, Canada, Finland, Italy, and the United States, have failed to find any association between Thimerosal exposure and autism. These studies examined trends in vaccine use, changes in autism frequency, and neuropsychological functioning, and found no relationship between Thimerosal-containing vaccines and autism.

In response to concerns about mercury exposure, Thimerosal was removed from many vaccines in 1999 as a precautionary measure. This decision was made by the Public Health Service agencies, the American Academy of Pediatrics, and vaccine manufacturers. While Thimerosal has been largely eliminated from childhood vaccines, it is still present in certain formulations of the influenza vaccine.

MMR vaccine and autism

In 1998, Andrew Wakefield, a British gastroenterologist, and his colleagues published a paper in The Lancet. The paper described 12 children, eight of whom were reported by their parents to have developed autism within a month of receiving the MMR vaccine. The paper was ultimately retracted, and there was no control group in the study. However, the publication sparked concerns about a link between the MMR vaccine and autism.

Subsequently, large epidemiological studies were conducted to investigate the potential association between the MMR vaccine and autism. These studies compared vaccination rates with autism diagnoses in different populations and considered various factors, such as the timing of diagnoses relative to vaccination and the presence of gastrointestinal symptoms. Despite these extensive investigations, no causal link was established between the MMR vaccine and autism.

The hypothesis then shifted to thimerosal, a preservative used in some childhood vaccines but not in the MMR vaccine. Multiple studies examined the relationship between thimerosal-containing vaccines and autism, including in Denmark and Sweden, where thimerosal had been removed from vaccines in 1992. These studies consistently found no association between thimerosal exposure and autism, and autism rates did not decline when thimerosal was removed from vaccines.

The debate around vaccines and autism has had significant impacts on public health. Despite strong evidence of vaccine safety, some parents remain hesitant to vaccinate their children due to uncertainties about potential links to autism. This hesitancy has led to outbreaks or resurgences of vaccine-preventable diseases such as measles.

Autism diagnoses and thimerosal exposure

Thimerosal is a preservative used in vaccines to prevent microbial growth and contamination. It has been used effectively in multidose vaccine preparations for over 50 years. Thimerosal is a mercurial compound that is approximately 50% mercury by weight. Due to concerns about paediatric exposure to mercury through vaccine administration, thimerosal was removed from many vaccines in 1999.

Despite the removal of thimerosal from vaccines, autism rates have continued to increase. This is evidenced by studies conducted in Denmark, Sweden, Quebec, and California, which all found that autism rates continued to increase despite the removal of thimerosal from vaccines. In Denmark, researchers compared the incidence of autism in children who received varying amounts of thimerosal and found no relationship between thimerosal exposure and autism. In Quebec, researchers grouped 27,749 children and estimated thimerosal exposure based on vaccine schedules. They found that thimerosal exposure and pervasive developmental disorder diagnosis were independent variables, with the highest rates of pervasive developmental disorder found in cohorts exposed to thimerosal-free vaccines.

In California, researchers found that the prevalence of autism increased from 0.6 per 1,000 live births in January 1995 to 4.1 per 1,000 live births in March 2007, even though exposure to thimerosal during infancy and early childhood declined during this period. Similarly, in Denmark and Sweden, autism rates continued to increase after thimerosal was removed from vaccines in 1992.

Several studies have specifically examined the potential association between thimerosal exposure and autism and have found no link between the two. For example, researchers in Finland analysed a cohort of 1.8 million children and found no vaccine-associated cases of autism. In the United States, researchers at the Centers for Disease Control and Prevention examined over 140,000 children and found no relationship between receipt of thimerosal-containing vaccines and autism. Additionally, a 2010 study by the CDC found no increased risk for autism spectrum disorder (ASD) in children with prenatal and infant exposure to thimerosal-containing vaccines.

Overall, the evidence suggests that there is no causal relationship between thimerosal exposure and autism. While concerns about paediatric exposure to mercury are valid, the removal of thimerosal from vaccines does not appear to have had an impact on autism rates.

Thimerosal and intestinal inflammation

Thimerosal, a preservative used in vaccine formulations, contains mercury, a naturally occurring element found in the earth's crust, air, soil, and water. It is a mercury-based preservative that has been used for decades in the United States in multi-dose vials of medicines and vaccines. Thimerosal is approximately 50% mercury by weight and is metabolized to ethylmercury and thiosalicylate.

Thimerosal has been the subject of numerous studies and has a long record of safe and effective use in preventing bacterial and fungal contamination of vaccines, with no ill effects other than minor local reactions at the site of injection. There is no evidence of harm caused by the low doses of thimerosal in vaccines, and research does not show any link between thimerosal in vaccines and autism. Even after thimerosal was removed from almost all childhood vaccines, autism rates continued to increase, contrary to the hypothesis that thimerosal causes autism.

One of the hypotheses proposed to explain the perceived link between vaccines and autism is that thimerosal, an ethylmercury-containing preservative in some vaccines, is toxic to the central nervous system. However, this hypothesis has not been supported by epidemiologic evidence or studies conducted in Denmark, Canada, Quebec, and the United States. These studies found no relationship between thimerosal exposure and autism, and the highest rates of pervasive developmental disorder were found in cohorts exposed to thimerosal-free vaccines.

While thimerosal has been generally considered safe, there have been some reports of high-dose thimerosal toxicity. In rabbits, intravenous thimerosal doses of 25 mg/kg of body weight resulted in fatalities from kidney and intestinal disease. Similarly, in rats, the tolerated dose was 45 mg/kg of body weight. However, it is important to note that the concentrations of thimerosal used in vaccines are much lower, typically ranging from 0.001% to 0.01%, and are considered safe and effective in preventing contamination.

In summary, while thimerosal does contain mercury and has been associated with minor local reactions at the injection site, there is no evidence to support a link between thimerosal-containing vaccines and autism or intestinal inflammation. The available data and studies suggest that thimerosal-containing vaccines are safe and effective in preventing bacterial and fungal contamination, and concerns about a potential link to autism or intestinal issues are not supported by the scientific evidence.

Frequently asked questions